Price Alert

Enliven Therapeutics Inc. (ELVN)

NASDAQ: ELVN · Real-Time Price · USD

20.15

0.14 (0.70%)

At close: Sep 05, 2025, 3:59 PM

20.15

0.00%

After-hours: Sep 05, 2025, 04:42 PM EDT

0.70% (1D)

Bid	19
Market Cap	1.19B
Revenue (ttm)	316K
Net Income (ttm)	-100.22M
EPS (ttm)	-1.99
PE Ratio (ttm)	-10.13
Forward PE	-9.48
Analyst	Buy

Ask	20.99
Volume	407,676
Avg. Volume (20D)	514,645
Open	20.28
Previous Close	20.01
Day's Range	19.89 - 20.89
52-Week Range	13.30 - 30.03
Beta	1.03

About ELVN

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol ELVN

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for ELVN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

2 months ago

+11.44%

Enliven Therapeutics shares are trading higher. Th... Unlock content with Pro Subscription

3 months ago

-10.41%

Enliven Therapeutics shares are trading lower after the company reported worse-than-expected Q1 EPS results.

News

1 week ago · zacks.com

How Much Upside is Left in Enliven Therapeutics, Inc. (ELVN)? Wall Street Analysts Think 102.41%

The consensus price target hints at a 102.4% upside potential for Enliven Therapeutics, Inc. (ELVN). While empirical research shows that this sought-after metric is hardly effective, an upward trend i...

1 month ago · zacks.com

Can Enliven Therapeutics, Inc. (ELVN) Climb 75.66% to Reach the Level Wall Street Analysts Expect?

The consensus price target hints at a 75.7% upside potential for Enliven Therapeutics, Inc. (ELVN). While empirical research shows that this sought-after metric is hardly effective, an upward trend in...